PF-9363

CAS No. 2569009-58-9

PF-9363( CTX-3648 )

Catalog No. M24156 CAS No. 2569009-58-9

PF-9363 is a potent and high selective KAT6A/KAT6B inhibitor. PF-9363 can be used for the research of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 In Stock
10MG 237 In Stock
25MG 375 In Stock
50MG 500 In Stock
100MG 696 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-9363
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-9363 is a potent and high selective KAT6A/KAT6B inhibitor. PF-9363 can be used for the research of cancer.
  • Description
    PF-9363 is a potent and high selective KAT6A/KAT6B inhibitor. PF-9363 can be used for the research of cancer.
  • In Vitro
    PF-9363 (0~1 μM; 1 day; ZR75-1, T47D and MCF7 cells) down-regulates the expression of H3K23Ac biomarker.PF-9363 leads to down regulation of a specific set of genes involved in ESR1 pathway, cell cycle and stem cell pathways. PF-9363 shows that the IC50 values for ZR75-1 and T47D are 0.3 nM and 0.9 nM. Western Blot Analysis Cell Line:ZR75-1, T47D and MCF7 cells Concentration:0~1 μM Incubation Time:1 day Result:Down-regulated the expression of H3K23Ac biomarker.
  • In Vivo
    PF-9363 shows strong anti-tumor activity in patient-derived xenograft models.
  • Synonyms
    CTX-3648
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    KAT6A/KAT6B
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2569009-58-9
  • Formula Weight
    444.46
  • Molecular Formula
    C20H20N4O6S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (112.50 mM)
  • SMILES
    O=S(C1=C(OC)C=CC=C1OC)(NC2=NOC3=C2C(OC)=CC(CN4N=CC=C4)=C3)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shikhar S, et al. First-in-class KAT6A/KAT6B Inhibitor CTx-648 (PF-9363) Demonstrates Potent Anti-tumor Activity in ER+ Breast Cancer with KAT6A Dysregulation
molnova catalog
related products
  • EZM0414

    EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.

  • MRTX-1719

    MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC 50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.

  • CBB3001

    CBB3001 (CBB-3001) is a novel potent, selective histone demethylase LSD1 inhibitor with IC50 of 21.25 uM.